Genentech, a member of the Roche Group , announced positive results from the Phase II FENopta study evaluating investigational oral fenebrutinib in adults with...
Nuevocor, a pre-clinical stage cardiac gene therapy company, announced that it will present new preclinical data on its adeno-associated virus (AAV) gene therapy for...
HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of first- and best-in-class small molecule allosteric therapies targeting regulatory sites on proteins...
